Platelet-CD40 ligand interaction with melanoma cell and monocyte CD40 enhances cellular procoagulant activity.
Platelet-tumor cell interactions are believed to be important in tumor metastasis. Tumor cell tissue factor (TF) expression enhances metastasis and angiogenesis, and is primarily responsible for tumor-induced thrombin generation and the formation of tumor cell-platelet aggregates. Activated platelets express and release CD40 ligand (CD40L), which induces endothelial TF expression by ligation to CD40. We investigated the effect of platelet-derived CD40L on the TF activity of human CD40-positive melanoma cells and monocytes by incubating supernatants from activated or resting platelets with tumor cells or monocytes, and by bringing resting or activated platelets into close apposition with tumor cell monolayers. CD40L was present on the surface of activated (but not resting) platelets and was also released following platelet activation. Both recombinant soluble CD40L (rsCD40L) and activated platelet supernatants increased procoagulant activity (PCA) and TF antigen in tumor cells and monocytes. The increase in TF activity induced by both rsCD40L and activated platelet supernatants was inhibited by anti-CD40L antibody. Furthermore, contact of activated platelets with tumor cells increased cellular PCA, and this effect was also inhibited by anti-CD40L. In malignancy, the increase in cellular TF activity via CD40 (tumor cell)-CD40L (platelet) interaction may possibly enhance intravascular coagulation and hematogenous metastasis.
Clinical and Research Laboratories, Florida Hospital Cancer Institute, Orlando 32804, USA. ali.amirkhosravi@flhosp.org
A
A
Amirkhosravi
M
M
Amaya
H
H
Desai
J L
JL
Francis
D001777:Blood Coagulation; D001792:Blood Platelets / Q000737:chemistry / Q000378:metabolism* / Q000502:physiology; D019013:CD40 Antigens / Q000378:metabolism*; D023201:CD40 Ligand / Q000378:metabolism* / Q000494:pharmacology; D002450:Cell Communication; D006801:Humans; D008545:Melanoma / Q000737:chemistry / Q000378:metabolism / Q000473:pathology*; D009000:Monocytes / Q000737:chemistry / Q000378:metabolism*; D015539:Platelet Activation / Q000502:physiology; D011994:Recombinant Proteins / Q000378:metabolism / Q000494:pharmacology; D012995:Solubility; D013925:Thromboplastin / Q000378:metabolism; D014407:Tumor Cells, Cultured; D015854:Up-Regulation
D019013:CD40 Antigens; D011994:Recombinant Proteins; D023201:CD40 Ligand; D013925:Thromboplastin